All terms
FDA Recall Classifications I, II, III
FDA's risk-based grading of recalls based on potential for harm.
Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026
Definition
Class I recalls involve a reasonable probability of serious adverse health consequences or death; Class II involves temporary or medically reversible harm; Class III is unlikely to cause adverse health consequences. What the regulation says
The FDA categorizes medical device recalls into three classes, I, II, and III, based on the degree of health hazard. This classification, outlined in 21 CFR Part 7, Subpart C, dictates the urgency and scope of action required from the recalling firm and the FDA. The FDA’s Regulatory Procedures Manual (RPM) Chapter 7 provides further guidance on recall policies and procedures.
What this means in practice
Classification determines public notification expectations and effectiveness-check rigor. The Recall Strategy and Health Hazard Evaluation drive the classification decision.Examples
- A manufacturer discovers a software bug in an implanted cardiac device that could cause it to stop functioning, leading to patient death. This would likely result in a Class I recall.
- A sterile surgical instrument is found to have minor, non-critical packaging defects that do not compromise sterility but might lead to user confusion. This could lead to a Class III recall.
- A diagnostic test kit produces slightly inaccurate results that could lead to a temporary misdiagnosis, but without permanent patient harm. This condition often results in a Class II recall.
Common pitfalls
- •Misinterpreting a Class II recall as less critical, potentially delaying appropriate corrective actions.
- •Failing to conduct a thorough Health Hazard Evaluation, which can lead to an incorrect recall classification.
- •Underestimating the resources required for a Class I recall, impacting the speed and effectiveness of product removal.
- •Not understanding that even Class III recalls require proper documentation and communication with the FDA.
- •Assuming that a recall classification is permanent and cannot be re-evaluated if new information arises.
Frequently asked questions
The primary factor is the Health Hazard Evaluation (HHE), which assesses the probability of adverse health consequences and their severity.
Cross-references
Part of
A larger framework or document this term belongs to.
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Post-Market
· Same categoryPost-Market
5-Day Report
Expedited FDA MDR for events requiring remedial action to prevent unreasonable risk of substantial harm.
Post-Market
Annual Report (PMA)
Yearly report required for Class III PMA devices summarizing changes, complaints, and post-approval study status.
Post-Market
Customer Notification Letter
Communication to users notifying them of a safety issue, corrective action, or important product information.
Post-Market
Electronic Medical Device Reporting(eMDR)
FDA's mandatory electronic submission system for Medical Device Reports.
Primary references
3 sourcesLink health: 3 verified· last checked 2026-06-20
FDA·2European Commission·1
- 1
FDA Recall ProceduresVerifiedFDAfda.gov
- 2
FDA Recalls - Medical DevicesVerifiedFDAfda.gov
- 3
EUDAMED Public SiteVerifiedEuropean Commissionec.europa.eu
Inline markers like [1] jump to the matching reference above.